Year All2026202520242023 Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance August 5, 2026 Read More Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026 July 16, 2026 Read More Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing July 14, 2026 Read More Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test July 1, 2026 Read More Caris Life Sciences Announces Dual Listing on NYSE Texas June 16, 2026 Read More Caris Life Sciences Announces Share Repurchase Program June 8, 2026 Read More Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing May 26, 2026 Read More Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek May 15, 2026 Read More Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels May 11, 2026 Read More Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization May 8, 2026 Read More
Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance August 5, 2026 Read More
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026 July 16, 2026 Read More
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing July 14, 2026 Read More
Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test July 1, 2026 Read More
Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing May 26, 2026 Read More
Caris Life Sciences Publishes Study on the Caris Lookback Program Demonstrating the Ongoing Clinical Value of Comprehensive Testing with Caris MI Cancer Seek May 15, 2026 Read More
Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels May 11, 2026 Read More
Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization May 8, 2026 Read More
